News

2026 · Paper

Nature Health accepts risk disparities study in principle

Our study, “Risk Disparities of Immune-Related Adverse Events in Diverse Racial Groups,” has been accepted in principle by Nature Health.

2026 · Paper

Integrating Multi-Dimensional Data to Advance Global Health Equity in Oncology

Our paper was published in Cancer Discovery, volume 16, issue 4, pages 660–664.

2026 · Paper

Sex Differences in Toxicities of CAR T-Cell Therapy

Our study is in press in Nature Communications.

2026 · Grant

American Cancer Society Institutional Research Grant (ACS-IRG)

Mapping Context-Specific E3–Target Landscapes to Enable Rational Targeted Protein Degrader Design

• PeriodJan–Dec 2026
• RolePI

2025 · Grant

Indiana Alzheimer’s Disease Research Center (IADRC) REC Scholar

Multi-Modal Integration to Characterize Sex Differences in Alzheimer’s Disease

• PeriodJul 2025–Jun 2026
• RolePI

2025 · Paper

Mapping T helper cell targets with deep learning

Our perspective in Nature Machine Intelligence examines the role of AI in mapping immunological targets.

2025 · Paper

Comprehensive transcriptional landscape of Alzheimer’s disease brains

Our work in Science Advances characterizes transcriptional programs and disease-associated signals in Alzheimer’s disease.

2024 · Grant

Ralph W. and Grace M. Showalter Research Trust Fund

Decoding the Effect of Genetic Variants on eRNA with Modern Statistical Methods

• PeriodJul 2024–Jun 2025
• RolePI

2024 · Paper

PancanQTLv2.0 expands cancer expression QTL analysis

Our paper in Nucleic Acids Research presents a comprehensive resource for expression quantitative trait loci across human cancers.

2024 · Paper

Pharmacogenomic and immune landscape of snoRNAs

Our research in Cancer Letters systematically examines snoRNAs across human cancers.

2023 · Paper

Expanding the PROTACtable genome universe

Our work in Nature Communications broadens the landscape of E3 ligases for targeted protein degradation.